Analytical Data
-
Gene name
NAP1L5
- Application
-
Alternative Names
1110020M21Rik; down regulated in liver malignancy; DRLM; NAP1L5; NP1L5_HUMAN; Nucleosome assembly protein 1-like 5
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96NT1
-
Expression Region
1-182 aa
-
AA Sequence
MADSENQGPA EPSQAAAAAE AAAEEVMAEG GAQGGDCDSA AGDPDSAAGQ MAEEPQTPAE NAPKPKNDFI ESLPNSVKCR VLALKKLQKR CDKIEAKFDK EFQALEKKYN DIYKPLLAKI QELTGEMEGC AWTLEGEEEE EEEYEDDEEE GEDEEEEEAA AEAAAGAKHD DAHAEMPDDA KK
-
Molecular Weight
19.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
NAP1L5, or Nucleosome Assembly Protein 1-like 5, is a member of the nucleosome assembly protein family, which plays a crucial role in chromatin remodeling and gene regulation. Research has shown that NAP1L5 is involved in the assembly and disassembly of nucleosomes, facilitating the proper packaging of DNA within the nucleus and influencing transcriptional activity. Given its pivotal role in cellular processes, alterations in NAP1L5 expression or function may contribute to various diseases, including cancer. Recent studies have focused on understanding the molecular mechanisms underlying NAP1L5's function, exploring its interactions with histones and other chromatin-associated proteins. Additionally, researchers are investigating how NAP1L5 may impact epigenetic regulation and chromatin dynamics during cell differentiation and development. Recombinant NAP1L5 proteins are being utilized in biochemical assays to delineate these interactions, providing insights into its role within the larger context of chromatin biology and potential therapeutic implications. Understanding the structural characteristics and functional dynamics of NAP1L5 not only enhances our knowledge of chromatin architecture but also opens avenues for targeted strategies in disease intervention.
